ARCHIVES

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

Pinkel, Sharp, Hausen Win GM Awards for ‘86

June 13, 1986

ASCO Picks University of Michigan Medical School Dean Allen Lichter As Exective Vice President and CEO.

July 14, 2006

NIH Defends NCI Sponsored Travel

December 3, 2010

NCI Calls Fisher “A Dominant Force” In Breast Cancer

September 5, 1997

FDA Authority To Regulate Off-Label Promotion Challenged In Federal Court.

January 15, 2010

SEER Data Show Under Age 55 Death Rates are Decreasing, Mixed Results In Various Categories

December 12, 1986